Filed 3mo ago· Feb 13, 2026
35 days to disclose
Gilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
RTX (Raytheon)
RTX
$1K-$15K
−6.4% vs S&P 500
Trade dateJan 9, 2026
RTX Corporation
⚑ Defense
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.




























































| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Feb 13, 2026 3mo ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | RTX (Raytheon) RTX RTX Corporation ⚑ Defense · Armed Services | Jan 9, 2026 35 days to disclose | Bad buy·−$635-7.9% −6.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 2, 2026 4mo ago | ![]() David J. Taylor RHouseOhio-02 | ↓sold | Vertex Pharmaceuticals VRTX - | Jan 29, 2026 4 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 15, 2026 4mo ago | ![]() Roger Williams RHouseTexas-25 | ↑bought | RTX (Raytheon) RTX RTX Corporation | Dec 22, 2025 24 days to disclose | Bad buy·−$502-6.3% −10.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 15, 2026 4mo ago | ![]() Julie Johnson DHouseTexas-32 | ↓sold | RTX (Raytheon) RTX JT RTX Corporation ⚑ Defense · Foreign Affairs | Dec 18, 2025 28 days to disclose | Flat·+0.0% +10.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | ![]() Julia Letlow RHouseLouisiana-05 | ↑bought | Vertex Pharmaceuticals VRTX - | Oct 23, 2024 447 days to disclose · 402 past 45-day window | Bad buy·−$738-9.2% −8.0% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 11, 2025 5mo ago | ![]() Julie Johnson DHouseTexas-32 | ↓sold | RTX (Raytheon) RTX JT RTX Corporation ⚑ Defense · Foreign Affairs | Nov 13, 2025 28 days to disclose | Flat·+0.0% +11.9% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 17, 2025 8mo ago | ![]() Dan Newhouse RHouseWashington-04 | ↓sold | RTX (Raytheon) RTX RTX Corporation | Aug 18, 2025 30 days to disclose | Flat·+0.0% +17.1% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 11, 2025 8mo ago | ![]() Julie Johnson DHouseTexas-32 | ↓sold | RTX (Raytheon) RTX JT RTX Corporation ⚑ Defense · Foreign Affairs | Aug 14, 2025 28 days to disclose | Flat·+0.0% +17.1% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2025 9mo ago | ![]() David J. Taylor RHouseOhio-02 | ↑bought | Vertex Pharmaceuticals VRTX - | Aug 7, 2025 26 days to disclose | Good buy·+$977+12.2% −2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | ![]() Lisa C. McClain RHouseMichigan-09 | ↓sold | Vertex Pharmaceuticals VRTX - ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 11, 2025 63 days to disclose · 18 past 45-day window | Flat·+0.0% +9.4% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | ![]() Lisa C. McClain RHouseMichigan-09 | ↓sold | Vertex Pharmaceuticals VRTX - ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 10, 2025 64 days to disclose · 19 past 45-day window | Flat·+0.0% +9.5% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | ![]() Lisa C. McClain RHouseMichigan-09 | ↑bought | Vertex Pharmaceuticals VRTX - ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Dec 11, 2024 245 days to disclose · 200 past 45-day window | Bad buy·−$711-8.9% −13.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 22, 2025 11mo ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↓sold | RTX (Raytheon) RTX RTX Corporation ⚑ Defense · Aviation | May 12, 2025 41 days to disclose | Flat·+0.0% +38.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jun 22, 2025 11mo ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↓sold | Vertex Pharmaceuticals VRTX - | May 12, 2025 41 days to disclose | Flat·+0.0% +9.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 16, 2025 1.0y ago | ![]() Dan Newhouse RHouseWashington-04 | ↓sold | RTX (Raytheon) RTX RTX Corporation | Apr 11, 2025 35 days to disclose | Flat·+0.0% +53.9% vs S&P 500 | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↑bought | RTX (Raytheon) RTX JT RTX Corporation ⚑ Defense · Permanent Select Committee on Intelligence | Apr 23, 2025 21 days to disclose | Good buy·+$3.6K+44.7% −8.1% vs S&P 500 | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | ![]() Julie Johnson DHouseTexas-32 | ↓sold | RTX (Raytheon) RTX JT RTX Corporation ⚑ Defense · Foreign Affairs | Apr 7, 2025 37 days to disclose | Flat·+0.0% +69.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 12, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↓sold | RTX (Raytheon) RTX | Apr 21, 2025 21 days to disclose | Flat·+0.0% +56.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 12, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↓sold | RTX (Raytheon) RTX RTX Corporation | Apr 21, 2025 21 days to disclose | Flat·+0.0% +56.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 23, 2025 1.1y ago | ![]() George Whitesides DHouseCalifornia-27 | ↓sold | RTX (Raytheon) RTX RTX Corporation ⚑ Defense · Armed Services | Mar 24, 2025 30 days to disclose | Flat·+0.0% +45.1% vs S&P 500 | $50K-$100K midpoint $75K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | RTX (Raytheon) RTX RTX Corporation | Mar 3, 2025 44 days to disclose | Good buy·+$2.4K+29.7% −20.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 14, 2025 1.1y ago | ![]() Byron Donalds RHouseFlorida-19 | ↓sold | Vertex Pharmaceuticals VRTX - | Mar 20, 2025 25 days to disclose | Flat·+0.0% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 14, 2025 1.1y ago | ![]() Byron Donalds RHouseFlorida-19 | ↓sold | Vertex Pharmaceuticals VRTX - | Mar 20, 2025 25 days to disclose | Flat·+0.0% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↑bought | Vertex Pharmaceuticals VRTX - | Mar 13, 2025 29 days to disclose | Bad buy·−$4.9K-15.2% −18.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Mar 12, 2025 1.2y ago | ![]() Julie Johnson DHouseTexas-32 | ↑bought | RTX (Raytheon) RTX JT RTX Corporation ⚑ Defense · Foreign Affairs | Feb 14, 2025 26 days to disclose | Good buy·+$3.4K+42.2% −7.3% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 9, 2025 1.2y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↑bought | RTX (Raytheon) RTX RTX Corporation ⚑ Defense · Aviation | Feb 24, 2025 13 days to disclose | Good buy·+$12.6K+38.8% −14.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Mar 9, 2025 1.2y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↑bought | Vertex Pharmaceuticals VRTX - | Feb 24, 2025 13 days to disclose | Bad buy·−$3.7K-11.4% −12.0% vs S&P 500 | $15K-$50K midpoint $32.5K |
Sep 6, 2024 1.7y ago | ![]() John James RHouseMichigan-10 | ↓sold | RTX (Raytheon) RTX RTX Corporation | Sep 4, 2024 2 days to disclose | Flat·+0.0% +59.8% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 21, 2024 1.8y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↓sold | RTX (Raytheon) RTX RTX Corporation ⚑ Defense · Foreign Affairs | Sep 27, 2023 329 days to disclose · 284 past 45-day window | Flat·+0.0% +115.7% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 14, 2024 1.8y ago | ![]() Greg Landsman DHouseOhio-01 | ↓sold | RTX (Raytheon) RTX RTX Corporation | Sep 21, 2023 328 days to disclose · 283 past 45-day window | Flat·+0.0% +114.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 15, 2024 1.9y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | RTX (Raytheon) RTX JT RTX Corporation | Jun 13, 2024 32 days to disclose | Good buy·+$5.3K+65.9% +34.3% vs S&P 500 | $1K-$15K midpoint $8K |
May 4, 2024 2.1y ago | ![]() Earl Blumenauer —HouseOregon-03 | ↑bought | RTX (Raytheon) RTX RTX Corporation | Apr 4, 2024 30 days to disclose | Good buy·+$6K+75.5% +36.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 25, 2024 2.1y ago | ![]() Dan Newhouse RHouseWashington-04 | ↑bought | RTX (Raytheon) RTX RTX Corporation | Apr 10, 2024 15 days to disclose | Good buy·+$5.8K+71.9% +33.1% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 12, 2024 2.1y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | RTX (Raytheon) RTX JT RTX Corporation | Mar 21, 2024 22 days to disclose | Good buy·+$6.8K+84.9% +48.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 24, 2024 2.4y ago | ![]() Blake D. Moore RHouseUtah-01 | ↑bought | RTX (Raytheon) RTX RTX | Jan 19, 2024 5 days to disclose | Good buy·+$181.1K+103.5% +14.9% vs S&P 500 | $100K-$250K midpoint $175K |
Jan 24, 2024 2.4y ago | ![]() Blake D. Moore RHouseUtah-01 | ↓sold | RTX (Raytheon) RTX RTX | Jan 19, 2024 5 days to disclose | Flat·+0.0% +88.6% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 9, 2023 2.6y ago | ![]() Greg Stanton DHouseArizona-04 | ↓sold | Vertex Pharmaceuticals VRTX | Oct 24, 2023 16 days to disclose | Flat·+0.0% +16.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 12, 2023 2.9y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | RTX (Raytheon) RTX Raytheon Technologies | Jun 15, 2023 27 days to disclose | Good buy·+$6.2K+77.8% +16.5% vs S&P 500 | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Karuna Therapeutics KRTX Karuna Therapeutics | Apr 10, 2023 39 days to disclose | price pending | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Mirati Therapeutics MRTX Mirati Therapeutics | Apr 10, 2023 39 days to disclose | price pending | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Mirati Therapeutics MRTX Mirati Therapeutics | Mar 31, 2023 17 days to disclose | price pending | $1K-$15K midpoint $8K |
Apr 10, 2023 3.2y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | RTX (Raytheon) RTX Raytheon Technologies | Mar 23, 2023 18 days to disclose | Good buy·+$6.5K+81.5% | $1K-$15K midpoint $8K |
Feb 24, 2023 3.3y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | RTX (Raytheon) RTX Raytheon Technologies ⚑ Defense · Homeland Security | Jan 31, 2023 24 days to disclose | Flat·+0.0% +100.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 14, 2023 3.3y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↓sold | RTX (Raytheon) RTX Raytheon Technologies | Jan 31, 2023 14 days to disclose | Flat·+0.0% +100.1% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2022 3.5y ago | ![]() Dwight Evans DHousePennsylvania-03 | ↓sold | RTX (Raytheon) RTX Raytheon Technologies | Nov 14, 2022 7 days to disclose | Missed gain·−$7K-87.5% −6.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 15, 2022 3.9y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | RTX (Raytheon) RTX Raytheon Technologies | Jun 16, 2022 29 days to disclose | Good buy·+$7.6K+94.7% | $1K-$15K midpoint $8K |
May 5, 2022 4.1y ago | ![]() William R. Keating DHouseMassachusetts-09 | ↑bought | Vertex Pharmaceuticals VRTX | Mar 29, 2022 37 days to disclose | Good buy·+$5.1K+63.4% +55.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 19, 2022 4.1y ago | ![]() John H. Rutherford RHouseFlorida-05 | ↓sold | RTX (Raytheon) RTX Raytheon Technologies | Mar 16, 2022 34 days to disclose | Flat·+0.0% +114.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 12, 2022 4.1y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | RTX (Raytheon) RTX Raytheon Technologies | Mar 24, 2022 19 days to disclose | Good buy·+$5.7K+70.6% −32.6% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 1, 2022 4.2y ago | ![]() Earl Blumenauer —HouseOregon-03 | ↓sold | RTX (Raytheon) RTX Corporation | Mar 14, 2022 18 days to disclose | Flat·+0.0% +117.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 1, 2022 4.2y ago | ![]() Earl Blumenauer —HouseOregon-03 | ↑bought | RTX (Raytheon) RTX Corporation | Feb 24, 2022 36 days to disclose | Good buy·+$6.2K+77.4% −42.3% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 16, 2022 4.2y ago | ![]() John H. Rutherford RHouseFlorida-05 | ↑bought | RTX (Raytheon) RTX Corporation | Feb 24, 2022 20 days to disclose | Good buy·+$6.1K+76.9% −42.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 11, 2022 4.4y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | RTX (Raytheon) RTX Corporation | Dec 16, 2021 26 days to disclose | Good buy·+$8.8K+109.8% −23.2% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 7, 2021 4.7y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | RTX (Raytheon) RTX Corporation | Sep 23, 2021 14 days to disclose | Good buy·+$375.2K+100.0% −18.3% vs S&P 500 | $250K-$500K midpoint $375K |
Oct 7, 2021 4.7y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | RTX (Raytheon) RTX Corporation | Sep 2, 2021 35 days to disclose | Good buy·+$79K+105.3% −10.9% vs S&P 500 | $50K-$100K midpoint $75K |
Jul 17, 2021 4.9y ago | ![]() Blake D. Moore RHouseUtah-01 | ↑bought | RTX (Raytheon) RTX Corporation | May 11, 2021 67 days to disclose · 22 past 45-day window | Good buy·+$8.8K+109.6% −1.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 17, 2021 4.9y ago | ![]() Blake D. Moore RHouseUtah-01 | ↑bought | RTX (Raytheon) RTX Corporation | Apr 30, 2021 78 days to disclose · 33 past 45-day window | Good buy·+$8.7K+109.3% +38.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 17, 2021 4.9y ago | ![]() Blake D. Moore RHouseUtah-01 | ↑bought | RTX (Raytheon) RTX Corporation | Mar 26, 2021 113 days to disclose · 68 past 45-day window | price pending | $1K-$15K midpoint $8K |
Jul 17, 2021 4.9y ago | ![]() Blake D. Moore RHouseUtah-01 | ↑bought | RTX (Raytheon) RTX Corporation | Feb 24, 2021 143 days to disclose · 98 past 45-day window | price pending | $1K-$15K midpoint $8K |
Jun 2, 2021 5.0y ago | ![]() David B. McKinley —HouseWest Virginia-01 | ↓sold | RTX (Raytheon) RTX Corporation | May 12, 2021 21 days to disclose | Flat·+0.0% +117.6% vs S&P 500 | $1K-$15K midpoint $8K |